Brilliant Bio Pharma

Hyderabad, India Founded: 1988 • Age: 38 yrs
Veterinary vaccine manufacturing services are provided to clients.

About Brilliant Bio Pharma

Brilliant Bio Pharma is a Healthcare company based in Hyderabad (India) founded in 1988 by TG Venkatesh. Veterinary vaccine manufacturing services are provided to clients. The company has 163 employees. Its Indian entity Brilliant Bio Pharma Private Limited reported revenue of β‚Ή174 Cr. Brilliant Bio Pharma offers products and services including Veterinary Vaccines and Animal Health Products. Its focus areas include Veterinary Health Products.

Company details

Brilliant Bio Pharma was founded in 1988 by TG Venkatesh in Hyderabad, India. Veterinary vaccine manufacturing services are offered within the biotechnology sector. Operations are centered on contract manufacturing for animal health products, including vaccine development and production. The company serves clients in the veterinary pharmaceuticals industry, with facilities located in India to support regional and international needs.

Key Metrics
  • Annual Revenue
    ₹174 Cr

    FY 2025 · +85% YoY

  • Net Profit
    ₹29.26 Cr

    FY 2025 · 17% margin

  • EBITDA
    ₹37.01 Cr

    FY 2025 · 21% margin

  • Latest Funding Round
    $225K (USD), Grant

    Apr 2018

  • Investors
  • Employee Count
    163

Products & Services of Brilliant Bio Pharma

Brilliant Bio Pharma offers a comprehensive portfolio of products and services, including Veterinary Vaccines and Animal Health Products.

Veterinary Vaccines
Biologicals

Vaccines for animals are developed and manufactured to support health management in livestock and companion animals

Animal Health Products
Medicines

Medicines and supplements for animals are produced to enhance wellness and address health issues in various species

Funding Insights of Brilliant Bio Pharma

  • Total Rounds 2
  • Last Round Grant β€” $224,997
  • First Round $262,635

    (Apr 2016)

  • Investors Count 1

All 2 funding rounds of Brilliant Bio Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2018$224,997Grant––
Apr 2016$262,635Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Brilliant Bio Pharma

Brilliant Bio Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Brilliant Bio Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Brilliant Bio Pharma Private Limited (Brilliant Bio Pharma)

Brilliant Bio Pharma Private Limited is the primary company behind Brilliant Bio Pharma. The board of Brilliant Bio Pharma Private Limited currently have 3 directors; the longest-serving is Hari Narayana Goluguri Reddy, appointed in 2013. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Hari Narayana Goluguri Reddy
DIN 02595735
Whole-time director10 Jun 201313 yrs 4 moBrilliant Bio Pharma Private Limited
Shukacharya Manur
DIN 08873674
Additional Director19 Aug 20206 yrs 2 moBrilliant Bio Pharma Private Limited
Bobba Venu Gopal Rao
DIN 11443309
Additional Director19 Dec 202510 moBrilliant Bio Pharma Private Limited

People of Brilliant Bio Pharma

5 people are tracked at Brilliant Bio Pharma (4 in leadership, 1 in team); the tracked headcount is 163.

NameRoleGroup
TG Venkatesh
FounderLeadership
Vice PresidentLeadership
Mourya Boda
Chairperson & Managing DirectorLeadership
Venkata Surya Subrahmanyam Yanamandra
General ManagerLeadership
Srinivas A
Trainee Officer In Regulatory AffairsTeam
Premium access

Complete people profiles for Brilliant Bio Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Brilliant Bio Pharma

Figures of Brilliant Bio Pharma Private Limited, the primary company behind Brilliant Bio Pharma, for FY 2025. Revenue was ₹174 Cr (+85% year on year). Net profit was ₹29.26 Cr (17% margin). EBITDA was ₹37.01 Cr (21% margin). Revenue has grown at a compounded annual rate of +40% over three years and +1% over five years.

  • ₹174 CrRevenue · FY 2025 · +85% YoY
  • ₹29.26 CrNet profit · 17% margin
  • ₹37.01 CrEBITDA · 21% margin
  • ₹12.71 CrPaid-up capital
  • 163Employees (provident fund records)
  • +40%Revenue CAGR, 3 years
  • +1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Brilliant Bio Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Brilliant Bio Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Brilliant Bio Pharma

3 dated milestones of Brilliant Bio Pharma across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Brilliant Bio Pharma is founded.
  2. Funding First funding round of $263K.
  3. Funding Latest funding round, Grant, of $225K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Brilliant Bio Pharma

Premium access

Complete news archive for Brilliant Bio Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brilliant Bio Pharma

Brilliant Bio Pharma was founded in 1988 and raised its 1st funding round 28 years after it was founded.

Brilliant Bio Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Brilliant Bio Pharma has 163 employees.

The primary company behind Brilliant Bio Pharma, Brilliant Bio Pharma Private Limited, reported revenue of β‚Ή174 Cr for FY 2025, up 85% year on year.

Brilliant Bio Pharma was founded in 1988 by TG Venkatesh in Hyderabad, India. Veterinary vaccine manufacturing services are offered within the biotechnology sector. Operations are centered on contract manufacturing for animal health products, including vaccine development and production. The company serves clients in the veterinary pharmaceuticals industry, with facilities located in India to support regional and international needs.

Brilliant Bio Pharma offers Veterinary Vaccines and Animal Health Products.

Brilliant Bio Pharma has 1 investor. Key investors include HHS.

Brilliant Bio Pharma operates through Brilliant Bio Pharma Private Limited.

The legal entities of Brilliant Bio Pharma currently have 5 directors, including Shukacharya Manur, Hari Narayana Goluguri Reddy, Mourya Boda and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available